Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 24, 2019JCI InsightOpen Access

Comorbid diabetes results in immune dysregulation and enhanced disease severity following MERS-CoV infection

View Full Paper
Ask AI
Bookmark
Share

Authors

KKKirsten KulcsarUniversity of Maryland, BaltimoreCCChristopher M. ColemanUniversity of NottinghamSBSarah E. BeckUniversity of Surrey

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Kulcsar et al. (2019) studied this question.

synapsesocial.com/papers/69dfa259acbf09c32e614a57https://doi.org/10.1172/jci.insight.131774
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Physiology and Pharmacology of DPP-4 in Glucose Homeostasis and the Treatment of Type 2 Diabetes2019 · 443 citations
  2. 2Sex differences in human adipose tissues – the biology of pear shape2012 · 1,158 citations
  3. 3International Diabetes Federation 20172018 · 13,571 citations
  4. 4Mouse-adapted MERS coronavirus causes lethal lung disease in human DPP4 knockin mice2017 · 192 citations
  5. 5Immune Responses to Middle East Respiratory Syndrome Coronavirus During the Acute and Convalescent Phases of Human Infection2018 · 156 citations